Figure 3 Cardiovascular disease, congestive heart failure, and demyelinating disorders were not increased in elderly subjects. Data points represent the difference in the proportion of subjects in treatment and control groups (percentage of subjects in etanercept treatment group – percentage of subjects in control groups) reporting cardiovascular (CV) events, CHF, and demyelinating disease. Error bars represent 95% CIs.